AtriCure (NASDAQ:ATRC) versus Neuronetics (NASDAQ:STIM) Financial Contrast
AtriCure (NASDAQ:ATRC – Get Rating) and Neuronetics (NASDAQ:STIM – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Institutional and Insider Ownership 93.3% of AtriCure shares are owned by institutional […]
Source: etfdailynews.com